The Food and Drug Administration needs to improve lax oversight of the financial conflicts of doctors who test medicines before they are approved for sale, according to a government watchdog report. The FDA lacks a complete list of doctors conducting research on new medicines and cannot determine which companies have submitted financial information for all doctors working on studies, according to a report by the Department of Health and Human Services Inspector General. Investigators examined materials submitted for 118 marketing applications of medicines or medical devices approved in fiscal 2007. Forty-two percent of the applications were missing financial information, the report said. The FDA did not document a review of any financial data for 31% of the applications.
The report urged the agency to take several steps to make sure companies submit complete financial information for doctors and that agency reviewers check the submissions. It also said the FDA should require companies to submit financial information for doctors before human clinical trials begin. The FDA objected to that idea, saying it would add another layer of review that would not necessarily help patients. It appears that the FDA generally agreed with the report’s recommendations.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.